Vyvanse® (lisdexamfetamine dimesylate) chewable tablet will be publically reimbursed in Ontario for ADHD treatment from March 31, 2020 for individuals (6 years and older) who require 12-hour continuous coverage due to academic and/or psychosocial needs
Read moreHow are you doing? With disrupted schedules, social isolation, non-essential services closing and anxiety about #COVID19, we know our #neurodiversesquad may be struggling! But we're also creative and resilient! How are you managing
Read moreMarch 24, 2020 - Toronto, Ontario The Centre for ADHD Awareness, Canada (CADDAC), announced today a strategic alliance with iMD Health Global that will help evolve communications between healthcare professionals and patients to improve health outcomes,
Read moreSeven brave teens and young adults share their thoughts and experiences with ADHD in a new five part YouTube video series created by CADDAC. Join Austin, Emily, Danni, Devin, Katelyn, Rebecca and Simon while they share some facts about ADHD, their thou
Read moreBy Guest Blogger: Jennifer E. Tiviluk, MA, RP, CCCSpecializing in Trauma, ADHD, Executive Functioning, Depression, Anxiety and Family of Origin Trauma “Doesn’t everyone have a little bit of ADHD?” “NO”!!!! ADHD is a neurodevelopmental disorder that aff
Read moreEvery 20th of February, as declared by the United Nations, the world observes a day of recognition for the need of more social justice. This year’s theme is: “Closing the Inequalities Gap to Achieve Social Justice”. The UN states that “We advance socia
Read more